Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | -25.00% | -25.00% | -14.29% |
03-25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
03-14 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Press Releases